191 related articles for article (PubMed ID: 11885027)
41. Osteopontin: role in cell signaling and cancer progression.
Rangaswami H; Bulbule A; Kundu GC
Trends Cell Biol; 2006 Feb; 16(2):79-87. PubMed ID: 16406521
[TBL] [Abstract][Full Text] [Related]
42. Glycosaminoglycan composition changes with MG-63 osteosarcoma osteogenesis in vitro and induces human mesenchymal stem cell aggregation.
Kumarasuriyar A; Murali S; Nurcombe V; Cool SM
J Cell Physiol; 2009 Mar; 218(3):501-11. PubMed ID: 18988189
[TBL] [Abstract][Full Text] [Related]
43. A new C-xylopyranoside derivative induces skin expression of glycosaminoglycans and heparan sulphate proteoglycans.
Pineau N; Bernerd F; Cavezza A; Dalko-Csiba M; Breton L
Eur J Dermatol; 2008; 18(1):36-40. PubMed ID: 18086587
[TBL] [Abstract][Full Text] [Related]
44. Proteoglycans remodeling in cancer: Underlying molecular mechanisms.
Theocharis AD; Karamanos NK
Matrix Biol; 2019 Jan; 75-76():220-259. PubMed ID: 29128506
[TBL] [Abstract][Full Text] [Related]
45. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
46. Heparan sulfate proteoglycans and the emergence of neuronal connectivity.
Van Vactor D; Wall DP; Johnson KG
Curr Opin Neurobiol; 2006 Feb; 16(1):40-51. PubMed ID: 16417999
[TBL] [Abstract][Full Text] [Related]
47. Structural insights into biological roles of protein-glycosaminoglycan interactions.
Raman R; Sasisekharan V; Sasisekharan R
Chem Biol; 2005 Mar; 12(3):267-77. PubMed ID: 15797210
[TBL] [Abstract][Full Text] [Related]
48. Perlecan--a multifunctional extracellular proteoglycan scaffold.
Farach-Carson MC; Carson DD
Glycobiology; 2007 Sep; 17(9):897-905. PubMed ID: 17442708
[TBL] [Abstract][Full Text] [Related]
49. Local proteolytic activity in tumor cell invasion and metastasis.
Ludwig T
Bioessays; 2005 Nov; 27(11):1181-91. PubMed ID: 16237672
[TBL] [Abstract][Full Text] [Related]
50. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
51. Perlecan signaling: helping hedgehog stimulate prostate cancer growth.
Datta S; Pierce M; Datta MW
Int J Biochem Cell Biol; 2006; 38(11):1855-61. PubMed ID: 16750652
[TBL] [Abstract][Full Text] [Related]
52. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
Hsia E; Richardson TP; Nugent MA
J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
[TBL] [Abstract][Full Text] [Related]
53. Chondroitin sulfate B and heparin mediate adhesion of Penicillium marneffei conidia to host extracellular matrices.
Srinoulprasert Y; Kongtawelert P; Chaiyaroj SC
Microb Pathog; 2006 Mar; 40(3):126-32. PubMed ID: 16455229
[TBL] [Abstract][Full Text] [Related]
54. Membrane type-matrix metalloproteinases and tumor progression.
Sounni NE; Noel A
Biochimie; 2005; 87(3-4):329-42. PubMed ID: 15781320
[TBL] [Abstract][Full Text] [Related]
55. The Belgian Society for Cell Biology and NFWO Research Community on Cell-Matrix Interactions. Heparan sulfate proteoglycans in development and malignancy. Ghent, Belgium, 7-8 1996. Proceedings and abstracts.
Cell Biol Int; 1997 Jan; 21(1):37-61. PubMed ID: 9072121
[No Abstract] [Full Text] [Related]
56. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture.
Harisi R; Dudás J; Timár F; Pogány G; Timár J; Kovalszky I; Szendroi M; Jeney A
Cell Biol Int; 2005 Nov; 29(11):959-67. PubMed ID: 16242975
[TBL] [Abstract][Full Text] [Related]
57. Specificities of heparan sulphate proteoglycans in developmental processes.
Perrimon N; Bernfield M
Nature; 2000 Apr; 404(6779):725-8. PubMed ID: 10783877
[TBL] [Abstract][Full Text] [Related]
58. Role of proteoglycans in cell adhesion of prostate cancer cells: from review to experiment.
Schamhart DH; Kurth KH
Urol Res; 1997; 25 Suppl 2():S89-96. PubMed ID: 9144893
[TBL] [Abstract][Full Text] [Related]
59. Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions.
Shriver Z; Liu D; Sasisekharan R
Trends Cardiovasc Med; 2002 Feb; 12(2):71-7. PubMed ID: 11852254
[TBL] [Abstract][Full Text] [Related]
60. Decreasing the metastatic potential in cancers--targeting the heparan sulfate proteoglycans.
Fjeldstad K; Kolset SO
Curr Drug Targets; 2005 Sep; 6(6):665-82. PubMed ID: 16178800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
